Silence Therapeutics (SLN) Change in Receivables (2024 - 2025)
Silence Therapeutics' (SLN) quarterly Change in Receivables came in at -$30000.0 in Q4 2025, down 104.91% year-on-year from $611000.0 in Q4 2024, and up 51.61% quarter-over-quarter from -$62000.0 in Q3 2025.
Silence Therapeutics (SLN) Change in Receivables (2024 - 2025) Analysis & Trends
Silence Therapeutics has disclosed Change in Receivables across 2 years of filings, most recently posting -$30000.0 for Q4 2025.
- Change in Receivables for Q4 2025 came in at -$30000.0, down 104.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$84000.0 (up 99.16% YoY), and the FY2025 annual result was -$1.0 million, down 213.27% from the prior year.
- Change in Receivables came in at -$30000.0 for Q4 2025 at Silence Therapeutics, up from -$62000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $10.0 million in Q1 2024 to a low of -$8.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -4.08 Mn |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -30,000.00 |
| Dec 31, 2025 | -30,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -940,000.00 |
| Mar 31, 2025 | -940,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Dec 31, 2024 | 611,000.00 |
| Sep 30, 2024 | -1.75 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -7.97 Mn |
| Jun 30, 2024 | -7.97 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Mar 31, 2024 | 10.01 Mn |